Back to
UBS Group AG
NVAX
29 quarters
Position history for
UBS Group AG's holdings in Novavax, Inc.
Yes. Ubs holds 1,869,659 shares of NVAX (Novavax), worth $17.6M, as of its Q2 2026 13F filing. It reduced the position by 2,608,042 shares (-58.3%) from Q1 2026. Ubs has held NVAX in every 13F on record since Q2 2019, 29 quarterly filings.
Current Value
$17.6M
Current Shares
1.9M
Total Value Change
+$17.6M
Total Shares Change
+1.9M
Quarter-by-Quarter History
Other major holders of NVAX: FMR LLC, RA Capital Management, L.P., Franklin Templeton Inc.